Isoliquiritigenin Reverses Epithelial-Mesenchymal Transition Through Modulation of the TGF-β/Smad Signaling Pathway in Endometrial Cancer

SIMPLE SUMMARY: The high recurrence risk and poor prognosis of metastatic endometrial cancer are the main focus of interventional therapy. In view of this, we established in vitro and in vivo metastasis models and explored the underlying mechanisms of the epithelial-mesenchymal transition (EMT) proc...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hsin-Yuan, Chiang, Yi-Fen, Huang, Jia-Syuan, Huang, Tsui-Chin, Shih, Yin-Hwa, Wang, Kai-Lee, Ali, Mohamed, Hong, Yong-Han, Shieh, Tzong-Ming, Hsia, Shih-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001359/
https://www.ncbi.nlm.nih.gov/pubmed/33799801
http://dx.doi.org/10.3390/cancers13061236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001359/
https://www.ncbi.nlm.nih.gov/pubmed/33799801
http://dx.doi.org/10.3390/cancers13061236

Ejemplares similares